Ramin Massoumi

Professor
More filtering options
  1. 2019
  2. Decreased expression of nemo-like kinase in melanoma is correlated with increased vascularity and metastasis

    Yang, Y., Zhe, H., Ramin Massoumi & Ke, H., 2019 Aug, In : Melanoma Research. 29, 4, p. 376-381 6 p.

    Research output: Contribution to journalArticle

  3. 2018
  4. Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1

    Mohamed Jemaà, Abassi, Y., Kifagi, C., Fezai, M., Renée Daams, Lang, F. & Ramin Massoumi, 2018 Dec 1, In : Scientific Reports. 8, 1, 11821.

    Research output: Contribution to journalArticle

  5. The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin

    Huang, X., Borgström, B., John Stegmayr, Abassi, Y., Kruszyk, M., Hakon Leffler, Lo Persson, Sebastian Albinsson, Ramin Massoumi, Ivan G. Scheblykin, Cecilia Hegardt, Stina Oredsson & Daniel Strand, 2018 Jun 27, In : ACS Central Science. 4, 6, p. 760-767 8 p.

    Research output: Contribution to journalArticle

  6. BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma article

    Wondossen Sime, Niu, Q., Abassi, Y., Masoumi, K. C., Zarrizi, R., Julie Bonne Køhler, Sven Kjellström, Lasorsa, V. A., Capasso, M., Fu, H. & Ramin Massoumi, 2018 Jan 1, In : Cell Death and Disease. 9, 5, 458.

    Research output: Contribution to journalArticle

  7. 2017
  8. UVB radiation represses CYLD expression in melanocytes

    Kuphal, S., Schneider, N., Ramin Massoumi, Hellerbrand, C. & Bosserhoff, A. K., 2017 Dec 1, In : Oncology Letters. 14, 6, p. 7262-7268 7 p.

    Research output: Contribution to journalArticle

  9. NLK-mediated phosphorylation of HDAC1 negatively regulates Wnt signaling

    Masoumi, K. C., Renée Daams, Wondossen Sime, Valentina Siino, Ke, H., Fredrik Levander & Ramin Massoumi, 2017 Jan 15, In : Molecular Biology of the Cell. 28, 2, p. 346-355 10 p.

    Research output: Contribution to journalArticle

  10. 2016
  11. CYLD and SUMO in neuroblastoma therapy

    Masoumi, K. C. & Ramin Massoumi, 2016, In : Oncoscience. 3, 1, p. 3-4 2 p.

    Research output: Contribution to journalArticle

  12. Cylindromatosis-A Protective Molecule against Liver Diseases.

    Hellerbrand, C. & Ramin Massoumi, 2016, In : Medicinal Research Reviews. 36, 2, p. 342-359

    Research output: Contribution to journalReview article

  13. Nemo-like kinase regulates the expression of vascular endothelial growth factor (VEGF) in alveolar epithelial cells

    Ke, H., Masoumi, K. C., Ahlqvist, K., Seckl, M. J., Kristina Rydell-Törmänen & Ramin Massoumi, 2016, In : Scientific Reports. 6, 23987.

    Research output: Contribution to journalArticle

  14. Putative role of SUMOylation in controlling the activity of deubiquitinating enzymes in cancer.

    Masoumi, K., Marfany, G., Wu, Y. & Ramin Massoumi, 2016, In : Future Oncology. 12, 4, p. 565-574

    Research output: Contribution to journalReview article

  15. 2015
  16. Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.

    Kobayashi, T., Masoumi, K. & Ramin Massoumi, 2015, In : Oncogene. 34, 17, p. 2251-2260

    Research output: Contribution to journalArticle

  17. Early diagnostic value of Bcl-3 localization in colorectal cancer.

    Saamarthy, K., Björner, S., Martin Johansson, Landberg, G., Ramin Massoumi, Karin Jirström & Masoumi, K., 2015, In : BMC Cancer. 15, 1, 341.

    Research output: Contribution to journalArticle

  18. Multifaceted role of the ubiquitin ligase Itch in immune regulation.

    Venuprasad, K., Zeng, M., Baughan, S. L. & Ramin Massoumi, 2015, In : Immunology and Cell Biology. 93, 5, p. 452-460

    Research output: Contribution to journalReview article

  19. The E3 ubiquitin ligase Itch inhibits p38α signaling and skin inflammation through the ubiquitylation of Tab1.

    Theivanthiran, B., Kathania, M., Zeng, M., Anguiano, E., Basrur, V., Vandergriff, T., Pascual, V., Wei, W-Z., Ramin Massoumi & Venuprasad, K., 2015, In : Science Signaling. 8, 365, p. ra22

    Research output: Contribution to journalArticle

  20. 2014
  21. Association of nuclear-localized nemo-like kinase with heat-shock protein 27 inhibits apoptosis in human breast cancer cells.

    Hallgren, G., Masoumi, K., Zarrizi, R., Hellman, U., Karlsson, P., Helou, K. & Ramin Massoumi, 2014, In : PLoS ONE. 9, 5, e96506.

    Research output: Contribution to journalArticle

  22. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.

    Rajeswara, P. R., Dorn, C., Ahlqvist, K., Bosserhoff, A. K., Hellerbrand, C. & Ramin Massoumi, 2014, In : Carcinogenesis. 35, 2, p. 461-468

    Research output: Contribution to journalArticle

  23. CYLD regulates HGF expression in hepatic stellate cells via interaction with HDAC7.

    Rajeswara, P. R., Dorn, C., Hellerbrand, C. & Ramin Massoumi, 2014, In : Hepatology. 60, 3, p. 1066-1081

    Research output: Contribution to journalArticle

  24. Deubiquitination of γ-tubulin by BAP1 prevents chromosome instability in breast cancer cells.

    Zarrizi, R., Menard, J., Mattias Belting & Ramin Massoumi, 2014, In : Cancer Research. 74, 22, p. 6499-6508

    Research output: Contribution to journalArticle

  25. 2013
  26. CYLD Enhances Severe Listeriosis by Impairing IL-6/STAT3-Dependent Fibrin Production

    Nishanth, G., Deckert, M., Wex, K., Ramin Massoumi, Schweitzer, K., Naumann, M. & Schlueter, D., 2013, In : PLoS Pathogens. 9, 6, e1003455.

    Research output: Contribution to journalArticle

  27. Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.

    Ahlqvist, K., Saamarthy, K., Syed Khaja, A. S., Anders Bjartell & Ramin Massoumi, 2013, In : Oncogene. 32, 12, p. 1601-1608

    Research output: Contribution to journalArticle

  28. PKC theta/beta and CYLD Are Antagonistic Partners in the NF kappa B and NFAT Transactivation Pathways in Primary Mouse CD3(+) T Lymphocytes

    Thuille, N., Wachowicz, K., Hermann-Kleiter, N., Kaminski, S., Fresser, F., Lutz-Nicoladoni, C., Leitges, M., Thome, M., Ramin Massoumi & Baier, G., 2013, In : PLoS ONE. 8, 1

    Research output: Contribution to journalArticle

  29. 2012
  30. A20 and CYLD Do Not Share Significant Overlapping Functions during B Cell Development and Activation

    Chu, Y., Soberon, V., Glockner, L., Beyaert, R., Ramin Massoumi, van Loo, G., Krappmann, D. & Schmidt-Supprian, M., 2012, In : Journal of Immunology. 189, 9, p. 4437-4443

    Research output: Contribution to journalArticle

  31. 2011
  32. Caspase 8 inhibits programmed necrosis by processing CYLD

    O'Donnell, M. A., Perez-Jimenez, E., Oberst, A., Ng, A., Ramin Massoumi, Xavier, R., Green, D. R. & Ting, A. T., 2011, In : Nature Cell Biology. 13, 12, p. 1437-U132

    Research output: Contribution to journalArticle

  33. CYLD: a deubiquitination enzyme with multiple roles in cancer.

    Ramin Massoumi, 2011, In : Future Oncology. 7, 2, p. 285-297

    Research output: Contribution to journalArticle

  34. GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma

    Kuphal, S., Shaw-Hallgren, G., Eberl, M., Karrer, S., Aberger, F., Bosserhoff, A. K. & Ramin Massoumi, 2011, In : Oncogene. 30, 44, p. 4523-4530

    Research output: Contribution to journalArticle

  35. Serum Response Factor Controls CYLD Expression via MAPK Signaling Pathway.

    Liang, G., Ahlqvist, K., Pannem, R., Posern, G. & Ramin Massoumi, 2011, In : PLoS ONE. 6, 5, e19613.

    Research output: Contribution to journalArticle

  36. The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation

    Ahmed, N., Zeng, M., Sinha, I., Polin, L., Wei, W-Z., Rathinam, C., Flavell, R., Ramin Massoumi & Venuprasad, K., 2011, In : Nature Immunology. 12, 12, p. 1176-U1

    Research output: Contribution to journalArticle

  37. Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer.

    Masoumi, K., Hallgren, G. & Ramin Massoumi, 2011, In : Journal of Skin Cancer. 2011, 614097.

    Research output: Contribution to journalArticle

  38. 2010
  39. Cyld: A Key Regulator Of Hepatocellular Apoptosis, Proliferation And Carcinogenesis

    Urbanik, T., Heine, S., Woerns, M., Hoevelmeyer, N., Boger, R. J., Maass, T., Ramin Massoumi, Faessler, R., Schuchmann, M., Galle, P. R., Waisman, A. & Schulze-Bergkamen, H., 2010, In : Journal of Hepatology. 52, p. S32-S33

    Research output: Contribution to journalPublished meeting abstract

  40. CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin

    Wickstroem, S. A., Masoumi, K. C., Khochbin, S., Faessler, R. & Ramin Massoumi, 2010, In : EMBO Journal. 29, 1, p. 131-144

    Research output: Contribution to journalArticle

  41. Expression of hair follicle stem cell markers in Cylindrospiradenomas

    Meier, N., Becker, A., Fleischer, M., Rose, C., Ramin Massoumi & Paus, R., 2010, In : Experimental Dermatology. 19, 2, p. 176-176

    Research output: Contribution to journalPublished meeting abstract

  42. Mutated cylindromatosis gene affects the functional state of dendritic cells

    Bros, M., Dexheimer, N., Besche, V., Masri, J., Trojandt, S., Hoevelmeyer, N., Reissig, S., Ramin Massoumi, Grabbe, S., Waisman, A. & Reske-Kunz, A. B., 2010, In : European Journal of Immunology. 40, 10, p. 2848-2857

    Research output: Contribution to journalArticle

  43. Persistent NFkappaB activation in malignant melanoma is generated through loss of the tumor suppressor CYLD

    Kuphal, S., Ramin Massoumi, Haas, B., Wild, P. J., Spruss, T., Pfeifer, A. & Bosserhoff, A. K., 2010, In : Experimental Dermatology. 19, 2, p. 209-209

    Research output: Contribution to journalPublished meeting abstract

  44. Persistent NFkappaB activation in malignant melanoma is generated through loss of the tumor suppressor CYLD

    Kuphal, S., Ramin Massoumi, Haas, B., Wild, P., Pfeifer, A. & Bosserhoff, A., 2010, In : European Journal of Cell Biology. 89, p. 1-1

    Research output: Contribution to journalPublished meeting abstract

  45. Ubiquitin chain cleavage: CYLD at work.

    Ramin Massoumi, 2010, In : Trends in Biochemical Sciences. 35, p. 392-399

    Research output: Contribution to journalArticle

  46. 2009
  47. CD47 regulates collagen I-induced cyclooxygenase-2 expression and intestinal epithelial cell migration.

    Broom, O., Zhang, Y., Oldenborg, P-A., Ramin Massoumi & Anita Sjölander, 2009, In : PLoS ONE. 4, 7, e6371.

    Research output: Contribution to journalArticle

  48. Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma

    Ramin Massoumi, Kuphal, S., Hellerbrand, C., Haas, B., Wild, P., Spruss, T., Pfeifer, A., Faessler, R. & Bosserhoff, A. K., 2009, In : Journal of Experimental Medicine. 206, 1, p. 221-232

    Research output: Contribution to journalArticle

  49. Naturally occurring short splice variant of CYLD positively regulates dendritic cell function

    Srokowski, C. C., Masri, J., Hoevelmeyer, N., Krembel, A. K., Tertilt, C., Strand, D., Mahnke, K., Ramin Massoumi, Waisman, A. & Schild, H., 2009, In : Blood. 113, 23, p. 5891-5895

    Research output: Contribution to journalArticle

  50. The Central Role of Bcl-3 in Atopic Dermatitis

    Ramin Massoumi, 2009, In : Journal of Investigative Dermatology. 129, 9, p. 2088-2090

    Research output: Contribution to journalDebate/Note/Editorial

  51. 2008
  52. Inactivation of the CYLD Deubiquitinase by HPV E6 Mediates Hypoxia-Induced NF-kappa B Activation

    An, J., Mo, D., Liu, H., Veena, M. S., Srivatsan, E. S., Ramin Massoumi & Rettig, M. B., 2008, In : Cancer Cell. 14, 5, p. 394-407

    Research output: Contribution to journalArticle

  53. The involvement of the tumor suppressor gene Cyld in autoimmune brain inflammation

    Hoevelmeyer, N., Reissig, S., Ramin Massoumi, Faessler, R. & Waisman, A., 2008, In : Wiener Klinische Wochenschrift. 120, Supplement 1, p. 156-156

    Research output: Contribution to journalPublished meeting abstract

  54. 2007
  55. Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control

    Ramin Massoumi & Paus, R., 2007, In : BioEssays. 29, 12, p. 1203-1214

    Research output: Contribution to journalReview article

  56. Reduced expression of CYLD in human colon and hepatocellular carcinomas

    Hellerbrand, C., Bumes, E., Bataille, F., Dietmaier, W., Ramin Massoumi & Bosserhoff, A. K., 2007, In : Carcinogenesis. 28, 1, p. 21-27

    Research output: Contribution to journalArticle

  57. Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD

    Hovelmeyer, N., Wunderlich, F. T., Ramin Massoumi, Jakobsen, C. G., Song, J., Worns, M. A., Merkwirth, C., Kovalenko, A., Aumailley, M., Strand, D., Bruning, J. C., Galle, P. R., Wallach, D. & Fässler, R., 2007, In : Journal of Experimental Medicine. 204, 11, p. 2615-2627

    Research output: Contribution to journalArticle

  58. The role of leukotriene receptor signaling in inflammation and cancer

    Ramin Massoumi & Anita Sjölander, 2007, In : Scientific World Journal. 7, p. 1413-1421

    Research output: Contribution to journalArticle

  59. 2006
  60. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling

    Ramin Massoumi, Chmielarska, K., Hennecke, K., Pfeifer, A. & Fassler, R., 2006, In : Cell. 125, 4, p. 665-677

    Research output: Contribution to journalArticle

  61. Cylindroma as tumor of hair follicle origin

    Ramin Massoumi, Podda, M., Fassler, R. & Paus, R., 2006, In : Journal of Investigative Dermatology. 126, 5, p. 1182-1184

    Research output: Contribution to journalArticle

  62. 2003
Previous 1 2 Next